The continuous bioprocessing industry is undergoing transformative growth, driven by increasing demand for efficient therapeutic production and advanced biomanufacturing technologies. Focused innovations and expanding applications have amplified both industry size and opportunities, establishing continuous bioprocessing as a critical enabler in biopharmaceutical manufacturing.  ...

The continuous bioprocessing industry is evolving rapidly, driven by advances in biopharmaceutical manufacturing that emphasize efficiency and scalability. Over recent years, the demand for streamlined production processes that reduce costs and time-to-market has propelled the sector’s innovation and expansion. This blog delivers detailed market analysis, revenue insights, and growth...

The continuous bioprocessing industry is evolving rapidly, driven by advances in biopharmaceutical manufacturing that emphasize efficiency and scalability. Over recent years, the demand for streamlined production processes that reduce costs and time-to-market has propelled the sector’s innovation and expansion. This blog delivers detailed market analysis, revenue insights, and growth...

NEWARK, Del., Aug. 25, 2026 — The global Bioinformatics in IVD Testing Market is expanding as diagnostic laboratories increasingly incorporate software-driven analysis, variant interpretation, knowledge management, and controlled reporting into molecular and genomic testing workflows. According to Future Market Insights (FMI), the market is projected to grow from USD 6.8 billion in 2026...

Small Molecule CDMO Market to Reach USD 133.63 Billion by 2034, Growing at 6.5% CAGR: Polaris Market Research According to a new report by Polaris Market Research, the global Small Molecule CDMO market was valued at USD 71.25 billion in 2024 and is projected to reach USD 133.63 billion by 2034, expanding at a CAGR of 6.5% over the forecast period. The market stood at an estimated USD 75.81...